You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
FLUVOXAMINE, SERUM/PLASMA |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB1283 Geisinger Epic ID: 53057 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Serum (preferred) or plasma | |
Preferred collection container: |
||
Alternate Collection Container: |
3 mL lavender-top (K2 EDTA) tube
|
|
Specimen required: |
3 mL serum (preferred) or plasma; minimum 1.2 mL | |
Special notes: |
Do not collect in serum separator or polymer gel separation tube. | |
| SPECIMEN PROCESSING |
||
Specimen processing instructions: |
Promptly centrifuge and separate serum or plasma into a plastic, screw-capped vial, using approved guidelines. | |
Transport temperature: |
Refrigerated. | |
Specimen stability: |
Room temperature: Not stable. Refrigerated: 30 days. Frozen: 90 days. | |
Rejection criteria: |
Serum Separator Tube (SST®). Polymer gel separation tube (PST). Received room temperature. | |
TEST DETAILS |
||
CPT code(s): |
80332 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Methodology: |
HPLC-MS/MS |
|
Synonyms: |
Quest test code 30529, Fluvoxamine
|
|
Clinical significance: |
Fluvoxamine (Luvox) is a drug that has been approved by the FDA for the treatment of obsessive-compulsive Disorders. It is a potent and selective serotonin reuptake inhibitor that has also shown effectiveness in treating depression and panic attacks. The FDA has initially approved its use for obsessive-compulsive disorders only. | |